Showing results (61-70 of 119) with videos related to
Sort By:
Pageof 12
Current Drug Safety|May 28, 2014
Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetineKyna M Gooden, Kristen B Bibeau, Jennifer Wood, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2026
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatmentPratik Bhagunde, Natasha Penner, Brian A Willis, et al.Experimental Neurology|May 19, 2005
Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphismsJung Lee, Hiroaki Fukumoto, Jennifer Orne, et al.Archives of Neurology|February 16, 2006
Relation of quantitative indexes of concurrent alpha-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer diseaseRoee Holtzer, Michael C Irizarry, Jody Sanders, et al.Journal of Alzheimer'S Disease : JAD|July 17, 2010
Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in JapanBeena Koshy, Akinori Miyashita, Pamela St Jean, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|August 10, 1999
Risperidone treatment of behavioral disturbances in outpatients with dementiaM C Irizarry, S N Ghaemi, E R Lee-Cherry, et al.Journal of Neuropathology and Experimental Neurology|June 15, 2006
Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable abeta42 levelsToshifumi Matsui, Karunya Ramasamy, Martin Ingelsson, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersAnthonin Reilhac, Tammie L S Benzinger, Kristin R Wildsmith, et al.Acta Neuropathologica|February 17, 2006
Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodiesJ Klucken, M Ingelsson, Y Shin, et al.Neuro-Degenerative Diseases|December 11, 2008
Plasma urate and progression of mild cognitive impairmentMichael C Irizarry, Rema Raman, Michael A Schwarzschild, et al.Pageof 12